Overexpression of fragile X gene (FMR-1) transcripts increases cAMP production in neural cells - PubMed (original) (raw)
Overexpression of fragile X gene (FMR-1) transcripts increases cAMP production in neural cells
E Berry-Kravis et al. J Neurosci Res. 1998.
Abstract
Fragile X syndrome results from amplification of an unstable trinucleotide (CGG) repeat in the first exon of FMR-1, the "fragile X gene." This mutation silences the gene, resulting in loss of expression of the FMR proteins (FMRP), a series of RNA-binding proteins generated by alternative splicing of FMR-1 transcripts. We have shown that cAMP production is diminished in cells from patients with fragile X syndrome. To establish a direct relationship between FMR-1 expression and cAMP metabolism, FMRP isoforms 1 and 7 were overexpressed in the neurotumor hybrid cell line HN2. Cyclic AMP production in clonal HN2 lines overexpressing FMRP was significantly higher than in nonoverexpressing control lines and increased with increasing total FMR-1 mRNA on Northern blots and FMRP signal on Western blots. These data support a role for FMRP in the regulation of cAMP signal transduction by increasing intracellular cAMP, perhaps through a mechanism involving binding and enhanced translation of mRNA(s) for cAMP cascade proteins. Diminished cAMP production in the absence of FMR-1 may provide one neurochemical mechanism through which FMR-1 influences cognitive function.
Similar articles
- Reduced cyclic AMP production in fragile X syndrome: cytogenetic and molecular correlations.
Berry-Kravis E, Hicar M, Ciurlionis R. Berry-Kravis E, et al. Pediatr Res. 1995 Nov;38(5):638-43. doi: 10.1203/00006450-199511000-00002. Pediatr Res. 1995. PMID: 8552427 - Novel point mutation within intron 10 of FMR-1 gene causing fragile X syndrome.
Wang YC, Lin ML, Lin SJ, Li YC, Li SY. Wang YC, et al. Hum Mutat. 1997;10(5):393-9. doi: 10.1002/(SICI)1098-1004(1997)10:5<393::AID-HUMU10>3.0.CO;2-V. Hum Mutat. 1997. PMID: 9375856 - [Detection of FMR-1 gene expression by RT-PCR].
Zheng L, Fan Y, Huang T, Zhu N, Shen Y, Wu G. Zheng L, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1995 Dec;17(6):407-11. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1995. PMID: 9208564 Chinese. - Biology of the fragile X mental retardation protein, an RNA-binding protein.
Khandjian EW. Khandjian EW. Biochem Cell Biol. 1999;77(4):331-42. Biochem Cell Biol. 1999. PMID: 10546896 Review. - [Molecular and genetic features of fragile X syndrome].
Jara L, Avendaño I, Aspillaga M, Blanco R. Jara L, et al. Rev Med Chil. 1996 Jul;124(7):865-72. Rev Med Chil. 1996. PMID: 9138377 Review. Spanish.
Cited by
- Targeted Treatments for Fragile X Syndrome.
Johnson D, Clark C, Hagerman R. Johnson D, et al. Adv Neurobiol. 2023;30:225-253. doi: 10.1007/978-3-031-21054-9_10. Adv Neurobiol. 2023. PMID: 36928853 - The cyclic AMP cascade is altered in the fragile X nervous system.
Kelley DJ, Davidson RJ, Elliott JL, Lahvis GP, Yin JC, Bhattacharyya A. Kelley DJ, et al. PLoS One. 2007 Sep 26;2(9):e931. doi: 10.1371/journal.pone.0000931. PLoS One. 2007. PMID: 17895972 Free PMC article. - Phenotypic Trade-Offs: Deciphering the Impact of Neurodiversity on Drug Development in Fragile X Syndrome.
Bui TA, Shatto J, Cuppens T, Droit A, Bolduc FV. Bui TA, et al. Front Psychiatry. 2021 Oct 18;12:730987. doi: 10.3389/fpsyt.2021.730987. eCollection 2021. Front Psychiatry. 2021. PMID: 34733188 Free PMC article. - Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial.
Berry-Kravis EM, Harnett MD, Reines SA, Reese MA, Ethridge LE, Outterson AH, Michalak C, Furman J, Gurney ME. Berry-Kravis EM, et al. Nat Med. 2021 May;27(5):862-870. doi: 10.1038/s41591-021-01321-w. Epub 2021 Apr 29. Nat Med. 2021. PMID: 33927413 Clinical Trial. - Using Drosophila as a tool to identify Pharmacological Therapies for Fragile X Syndrome.
McBride SM, Holloway SL, Jongens TA. McBride SM, et al. Drug Discov Today Technol. 2012 Sep 24;10(1):e129-e136. doi: 10.1016/j.ddtec.2012.09.005. Drug Discov Today Technol. 2012. PMID: 23730322 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical